Of note, in patients with steatohepatitis, the serum VAP-1 levels correlate with the severity of obesity, steatohepatitis, and, more importantly, the fibrosis stage [20], but LOLA or VitE does not alter it. The gene discussed is AOC3; the disease is obesity disorder.